65,437 trials
Patent Ductus Arteriosus
Primary: False Positives Results of Pocket Echocardiography System (PES) Detection of Patent Ductus Arteriosus (PDA) to Full Featured Echo System (FFES) — 10.8 percentage of…
Healthy, no Evidence of Disease · Hot Flashes
Primary: Percent of Baseline in Average Hot Flash Activity (Score and Frequency) — 64.6; 67.4 Percent of baseline — p=0.0903
Coronary Artery Disease
Primary: The Accuracy (Percent of Correct Decisions) of Post-dilatation Decisions Based on the Stent Optimizer (SO) Software, With IVUS as Gold Standard. — 100 percentage of…
Squamous Cell Carcinoma of Nasopharynx · Squamous Cell Carcinoma of Oropharynx · Squamous Cell Carcinoma of Hypopharynx
Primary: Incidence and / or Severity of Oral Mucositis — 19; 3 Grade 3-4 oral mucositis — p=0.05
Cystic Fibrosis · Exocrine Pancreatic Insufficiency
Primary: Treatment Difference for Acceptability of Treatment — 1.5; 3.5; 2.5; 1.0 units on a scale
Alopecia · Alopecia, Androgenetic · Baldness
Primary: Change From Baseline in Target Area Hair Count (TAHC) — 135.0; 145.7; 151.5; 143.7 terminal hairs/cm^2
Breast Neoplasms
Primary: Disease-Free Survival (DFS) at Month 36 Post-Randomization: Main Study — 0.90; 0.86 probability of DFS — p=0.00003
Healthy
Primary: Adverse Events That Meet Dose-limiting Toxicity Criteria Specified in Protocol. — 0; 0; 0; 0 participants
Adult Lymphocyte Depletion Hodgkin Lymphoma · Adult Lymphocyte Predominant Hodgkin Lymphoma · Adult Mixed Cellularity Hodgkin Lymphoma
Primary: Complete Response (CR) — 2; 21 participants
Multiple Myeloma
Primary: Progression Free Survival — 3; 9 participants
Typhoid Fever
Primary: Percentage of Subjects With at Least 4-fold Increase in Anti-Vi Enzyme-linked Immunosorbent Assay (ELISA) Titer — 100; 100; 100; 11 percentage of subjects
Venous Thrombosis
Primary: Incidence of Adjudicated Composite of Symptomatic, Recurrent Venous Thromboembolism (VTE) or VTE-Related Death During 6 Months of Treatment — 0.0226; 0.0269 proportion…
Exocrine Pancreatic Insufficiency · Cystic Fibrosis
Primary: Percent Coefficient of Fat Absorption (CFA) — 78.27; 80.35 percent CFA — p=0.4590
Cystic Fibrosis · Pancreatic Insufficiency
Primary: Percent Coefficient of Fat Absorption (CFA) — 34.5; 82.7 Percent CFA — p=0.0013
Breast Cancer · Depression · Fatigue
Primary: Stimulated ln (TNF-a) — 8.31; 8.39; 8.31; 8.44 ln (pg/mL) — p=0.20